Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pioglitazone in NASH
NCT00013598Phase 2Completed
- Sponsor
- National Institute of Diabetes and Digestive and Kidney Diseases
- Start
- Mar 2001
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pioglitazone in Nonalcoholic steatohepatitis (NASH), sponsored by National Institute of Diabetes and Digestive and Kidney Diseases. Started Mar 2001; status: completed.
02
Drugs
pioglitazone
03
Conditions
Nonalcoholic steatohepatitis (NASH)
Beyond the preview
Go deeper on NCT00013598.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00013598.